Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Glaxo Grp drug BREO ELLIPTA appeared first on…
New patent expiration for Glaxo Grp drug BREO ELLIPTA Read Post »
Annual Drug Patent Expirations for ANORO+ELLIPTA Anoro Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Glaxosmithkline drug ANORO…
New patent expiration for Glaxosmithkline drug ANORO ELLIPTA Read Post »
INBRIJA (levodopa) Acorda Patent: 9,155,699 Expiration: Mar 19, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Patent …
Drug Patent Expirations for the Week of March 19, 2023 Read Post »
Annual Drug Patent Expirations for KYNAMRO Kynamro is a drug marketed by Kastle Theraps Llc and is included in one NDA. There are three patents protecting this drug. This drug…
The post New patent expiration for Kastle Theraps drug KYNAMRO appeared fir…
New patent expiration for Kastle Theraps drug KYNAMRO Read Post »
Annual Drug Patent Expirations for TEGSEDI Tegsedi is a drug marketed by Akcea Theraps and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent expiration for Akcea Theraps drug TEGSEDI appeared first on…
New patent expiration for Akcea Theraps drug TEGSEDI Read Post »
Annual Drug Patent Expirations for OTEZLA Otezla is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent expiration for Amgen Inc drug OTEZLA appeared first on DrugPat…
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are ten patents protecting…
The post New patent expiration for Acorda drug INBRIJA appeared first on Dr…
Annual Drug Patent Expirations for GATTEX+KIT Gattex Kit is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Takeda Pharms drug GATTEX KIT appeared first o…
New patent expiration for Takeda Pharms drug GATTEX KIT Read Post »
Annual Drug Patent Expirations for SUMAVEL+DOSEPRO Sumavel Dosepro is a drug marketed by Endo Ventures Ltd and is included in one NDA. There are nine patents protecting this drug. SUMAVEL…
The post New patent expiration for Endo Ventures drug SUMAVEL D…
New patent expiration for Endo Ventures drug SUMAVEL DOSEPRO Read Post »
Annual Drug Patent Expirations for PATANASE Patanase is a drug marketed by Novartis and is included in one NDA. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for Novartis drug PATANASE appeared fir…
New patent expiration for Novartis drug PATANASE Read Post »